enGene Holdings Inc. (ENGN)
(Delayed Data from NSDQ)
$3.68 USD
+0.11 (3.08%)
Updated Aug 8, 2025 04:00 PM ET
After-Market: $3.71 +0.03 (0.82%) 7:58 PM ET
3-Hold of 5 3
B Value F Growth B Momentum D VGM
Fundamental Charts
About Market Cap
As of the previous market close, enGene Holdings Inc. has a market cap of $182.45M, which represents its share price of $3.57 multiplied by its outstanding shares number of 51.10M. As a small-cap company, ENGN's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
ENGN 3.68 +0.11(3.08%)
Will ENGN be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for ENGN based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ENGN
Best Momentum Stocks to Buy for February 19th
New Strong Buy Stocks for February 19th
ENGN: What are Zacks experts saying now?
Zacks Private Portfolio Services
How Much Upside is Left in enGene Holdings Inc. (ENGN)? Wall Street Analysts Think 238.77%
enGene Holdings Inc. (ENGN) Upgraded to Strong Buy: Here's Why
Here's Why enGene Holdings Inc. (ENGN) is Poised for a Turnaround After Losing -16.9% in 4 Weeks
Other News for ENGN
enGene Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) | ENGN Stock News
enGene Announces Board and Leadership Appointments to Support Commercial Readiness | ENGN Stock News
enGene names Matthew Boyd CRO, Jill Buck CDO
Wells Fargo Reaffirms Their Buy Rating on enGene Holdings (ENGN)
FDA Grants RMAT Designation for enGene's Detalimogene, Enabling Potential for Expedited Review ...